The Valley Desk

Clinical trial reportOphthalmologyPublished

Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, Wills Eye Hospital. Affiliation source

Publication record

Type
Clinical trial report
Venue
Ophthalmology
Published
Subject terms
Humans; Diabetic Retinopathy; Macular Degeneration; Angiogenesis Inhibitors; Treatment Outcome; Visual Acuity; Wet Macular Degeneration; Intravitreal Injections; Ranibizumab; VEGF; Implant; Age-related macular degeneration
PubMed ID
36870451
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal